Aimei Health Technology Co., Ltd.
AFJKRNext catalyst
No upcoming catalyst in our data
No upcoming FDA decision, filing or trial readout is on file for AFJKR. That does not mean none is planned.
Get an email about AFJKR's next catalysts
Track Aimei Health Technology Co. (AFJKR) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
0 upcoming, 0 past
No catalysts found.
Market Overview
Stock performance and key metrics
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
23-valent pneumococcal polysaccharide vaccine | Phase 3 | Pneumococcal Disease | - | - |
Frequently asked questions
What is in Aimei Health Technology Co., Ltd.'s drug pipeline?→
CatalystAlert tracks 1 drug candidate in Aimei Health Technology Co., Ltd.'s (AFJKR) pipeline across Phase 3. Its lead program is 23-valent pneumococcal polysaccharide vaccine (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Aimei Health Technology Co., Ltd.'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for Aimei Health Technology Co., Ltd. (AFJKR) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track AFJKR biotech catalysts?→
Add AFJKR to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Aimei Health Technology Co., Ltd.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.